March 27, 2023
MarketWatch
Dow Jones Newswires: Novartis gets positive result from breast-cancer drug trial
The Phase 3 trial, named Natalee, was stopped early as the primary endpoint has been met, Novartis sa... See more »
XBiotech, Inc.: XBiotech's revenue changed from 18.39M in Dec 2021 to 14.04M in Mar 2022
XBiotech’s Trailing Twelve Months revenue changed from $18.39M in Dec 2021 to $14.04M in Mar 2022 decreasing 23.6% in this time period.
Read full article »
March 25, 2023
The Wall Street Journal
Regeneron, Sanofi Look for Billions From COPD Drug
The companies said Dupixent showed positive results in a late-stage study of current or former smoker... See more »
March 27, 2023
MarketWatch
Dow Jones Newswires: Novartis gets positive result from breast-cancer drug trial
The Phase 3 trial, named Natalee, was stopped early as the primary endpoint has been met, Novartis sa... See more »
March 25, 2023
The Wall Street Journal
Regeneron, Sanofi Look for Billions From COPD Drug
The companies said Dupixent showed positive results in a late-stage study of current or former smoker... See more »
XBiotech is a biopharmaceutical company that develops antibody therapies for inflammatory diseases and colorectal cancer.
Read more